Topical NTX application restores tear production and corneal sensitivity, and increases the amount of aquaporin-5 expression in lacrimal gland acinar cells, but does not alter the defective morphology of the lacrimal functional unit suggesting that the rapid reversal of dry eye is related to corneal nerve sensitivity. The gene discussed is AQP5; the disease is dry eye syndrome.